Načítá se...
Short-form Ron is a novel determinant of ovarian cancer initiation and progression
Short-form Ron (sfRon) is an understudied, alternative isoform of the full-length Ron receptor tyrosine kinase. In contrast to Ron, which has been shown to be an important player in many cancers, little is known about the role of sfRon in cancer pathogenesis. Here we report the striking discovery th...
Uloženo v:
| Vydáno v: | Genes Cancer |
|---|---|
| Hlavní autoři: | , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Impact Journals LLC
2016
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4979590/ https://ncbi.nlm.nih.gov/pubmed/27551332 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/genesandcancer.109 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|